Dual antiangiogenic therapy using lenalidomide and bevacizumab with docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC). Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Adesunloye, Bamidele
  • Huang, Xuan
  • Ning, Yangmin M
  • Madan, Ravi A
  • Gulley, James L
  • Beatson, Melony
  • Kluetz, Paul Gustav
  • Adelberg, David E
  • Arlen, Philip M
  • Parnes, Howard L
  • Mulquin, Marcia
  • Steinberg, Seth M
  • Wright, John Joseph
  • Trepel, Jane B
  • Dawson, Nancy Ann
  • Chen, Clara
  • Bassim, Carol Walker
  • Apolo, Andrea Borghese
  • Figg, William Douglas
  • Dahut, William L

publication date

  • May 20, 2012